ChoA Pharmaceutical Co., LTD. Logo

ChoA Pharmaceutical Co., LTD.

Global manufacturer of OTC medicines and health supplements distributed through pharmacies.

034940 | KO

Overview

Corporate Details

ISIN(s):
KR7034940007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 당산로2길 12 에이스테크노타워 101호(문래동3가, 에이스테크노타워1층), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1988, ChoA Pharmaceutical Co., LTD. develops, manufactures, and supplies a range of pharmaceutical products and health foods. The company's portfolio includes approximately 200 products, specializing in over-the-counter (OTC) medicines, health supplements, digestives, and nutritional tonics. ChoA Pharmaceutical is recognized for its various product formulations, including tablets, capsules, liquids, and a significant line of drinkable ampoule products. The company focuses on pharmacies as its primary distribution channel and maintains a global business presence, exporting its products to various regions in Asia, the Middle East, and the Americas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.3 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 586.6 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 137.2 KB
2025-02-28 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 139.1 KB
2025-02-21 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.1 KB
2025-02-21 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2025-02-03 00:00
Regulatory News Service
생산재개(자율공시)
Korean 7.8 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-10 00:00
Regulatory News Service
생산중단
Korean 8.9 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 934.8 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 1.0 MB
2024-05-17 00:00
Related Party Transaction
계열회사변경(자율공시)
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all ChoA Pharmaceutical Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ChoA Pharmaceutical Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ChoA Pharmaceutical Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.